Rothschedl, E. and Wolf, S. (2023): Olaparib (Lynparza®) in combination with abiraterone and prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Oncology Fact Sheet Nr. 117.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
822kB |
Item Type: | Oncology Fact Sheet |
---|---|
Subjects: | QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics WJ Urogenital system > WJ 700-875 Male genitalia |
Language: | English |
Series Name: | Oncology Fact Sheet Nr. 117 |
Deposited on: | 01 Feb 2023 15:37 |
Last Modified: | 01 Feb 2023 15:52 |
Repository Staff Only: item control page